Bausch Health Companies (BHC) EBIT Margin (2009 - 2026)

Bausch Health Companies has disclosed EBIT Margin across 18 years of filings, most recently posting 25.95% for Q2 2026.

• In Q2 2026, EBIT Margin rose 840.0% year-over-year to 25.95%; the TTM figure through Jun 2026 stood at 8.14% (down 805.0% YoY), while the FY2025 annual figure was 17.66%, up 160.0% from the prior year.
• EBIT Margin came in at 25.95% for Q2 2026 at Bausch Health Companies, up from 37.64% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 25.95% in Q2 2026 to a low of 37.64% in Q1 2026.
• Average EBIT Margin over 5 years is 10.54%, with a median of 13.96% recorded in 2024.
• Year-over-year, EBIT Margin surged 2579 bps in 2023 and tumbled 4986 bps in 2026.
• Over 5 years, EBIT Margin stood at 10.76% in 2022, then jumped by 240 bps to 15.03% in 2023, then soared by 45 bps to 21.81% in 2024, then fell by 22 bps to 16.95% in 2025, then soared by 53 bps to 25.95% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 25.95% in Q2 2026, 37.64% in Q1 2026, and 16.95% in Q4 2025.